Kirin Holdings Co (KNBWY) AI Stock Analysis

• Market Cap: $12.20B
• Dividend Yield: 2.25%
• Average Volume (3M): 1.02K
• Price to Earnings (P/E): 21.9
• Beta (1Y): -0.13
• Revenue Growth: 5.64%
• EPS Growth: -22.32%
• Country: US
• Employees: 31,934
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Beverages - Alcoholic
• EPS (TTM): 0.40
• Shares Outstanding: 914,000,000
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 1,024
• PEG Ratio: -0.59
• Price to Book (P/B): 1.40
• Price to Sales (P/S): 0.71
• P/FCF Ratio: 26.56
• Enterprise Value/Market Cap: 1.44
• Enterprise Value/Revenue: <0.01
• Enterprise Value/Gross Profit: 0.02
• Enterprise Value/Ebitda: 0.09
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 68 Neutral
• Price Target: $16.50 ▲(9.56% Upside)

Kirin Holdings Co's overall stock score reflects a challenging financial environment with declining revenue and profitability, which is the most significant factor. The technical analysis shows a slightly positive trend, providing some support to the stock. The valuation indicates a relatively high P/E ratio, suggesting limited upside potential. The absence of earnings call and corporate events data means these factors do not influence the score.

Positive Factors

Diversified Product Portfolio

Kirin's diversified portfolio across alcoholic and non-alcoholic beverages, food, and pharmaceuticals provides resilience against market fluctuations, supporting long-term stability.

Healthy Gross Profit Margin

A strong gross profit margin indicates efficient production and pricing strategies, which can sustain profitability even amid revenue challenges.

Strategic Partnerships

Partnerships expand market access and distribution capabilities, strengthening Kirin's competitive position and supporting revenue growth.

Negative Factors

Declining Revenue Growth

A sharp decline in revenue growth suggests challenges in market demand or competitive positioning, potentially impacting long-term financial health.

Increased Leverage

Higher leverage can increase financial risk and limit flexibility, potentially affecting Kirin's ability to invest in growth opportunities.

Negative Free Cash Flow Growth

Negative free cash flow growth indicates cash generation challenges, which may constrain Kirin's ability to fund operations and strategic initiatives.

Kirin Holdings Co Business Overview & Revenue Model

Company Description

Kirin Holdings Company, Limited produces and sells alcoholic beverages, soft drinks, pharmaceuticals, and other related products in Japan and internationally. It operates through four segments: Japan Beer and Spirits Businesses, Japan Non-Alcoholic Beverages Business, Oceania Integrated Beverages Business, and Pharmaceuticals Business. The company's products include beer, happo-shu, wine, whiskey, spirits, soft drinks, dairy products, fruit juices, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products. In addition, the company engages in the factories and theme park businesses; management and operation of a chain of Kirin City beer pubs; and manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use bulk pharmaceuticals, as well as margarine, jams, and honey. Further, it is involved in the manufacture and sale of Coca-Cola products and other soft drinks, and sake and other food products; as well as manufacture and supply of Four Roses bourbon; and acts as an insurance agent. The company was formerly known as Kirin Brewery Company, Limited and changed its name to Kirin Holdings Company, Limited in July 2007. Kirin Holdings Company, Limited was founded in 1885 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Kirin Holdings generates revenue through multiple key streams, primarily from the sale of alcoholic beverages, including beers, wines, and spirits, which constitute a significant portion of its income. The company also earns revenue from non-alcoholic beverages, such as soft drinks and health products. Kirin's business model benefits from a strong brand presence in both domestic and international markets, with strategic partnerships and distribution agreements that enhance its market reach. The company has also invested in the food sector, providing additional revenue opportunities, while its pharmaceutical division contributes to earnings through the development and sale of health-related products. Overall, Kirin's diversified product portfolio and market strategies are crucial in driving its overall financial performance.

Kirin Holdings Co Financial Statement Overview

Summary

Kirin Holdings Co is facing a challenging financial period with declining revenue and profitability. The increased leverage on the balance sheet poses financial risks, and cash flow metrics indicate significant pressure with negative free cash flow growth. Despite a healthy gross profit margin, strategic adjustments are needed to improve growth and cash flow management.

Income Statement

Kirin Holdings Co experienced a significant decline in revenue growth with a -25.21% rate in TTM (Trailing-Twelve-Months), indicating a challenging period. The gross profit margin remains healthy at 46.10%, but the net profit margin has decreased to 2.26%, reflecting reduced profitability. EBIT and EBITDA margins are also lower than previous years, suggesting pressure on operational efficiency.

Balance Sheet

The company's debt-to-equity ratio increased to 0.91 in TTM, indicating higher leverage, which could pose financial risk. Return on equity is modest at 4.70%, showing limited profitability from equity. The equity ratio stands at 35.34%, suggesting a balanced capital structure but with increased debt levels.

Cash Flow

Kirin Holdings Co faced a significant decline in free cash flow growth at -239.42% in TTM, highlighting cash flow challenges. The operating cash flow to net income ratio is 0.25, indicating moderate cash generation relative to net income. The free cash flow to net income ratio is low at 0.08, reflecting constrained free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.78T	2.34T	2.13T	1.99T	1.82T	1.85T
Gross Profit	821.70B	1.07T	963.47B	905.71B	822.84B	803.88B
EBITDA	190.29B	253.42B	294.80B	251.27B	227.59B	215.18B
Net Income	32.12B	58.21B	112.70B	111.01B	59.79B	71.94B
Balance Sheet
Total Assets	22.41B	3.35T	2.87T	2.54T	2.47T	2.46T
Cash, Cash Equivalents and Short-Term Investments	891.86M	127.19B	140.34B	96.44B	157.40B	169.62B
Total Debt	6.61B	857.57B	656.40B	523.12B	551.47B	642.64B
Total Liabilities	12.55B	1.82T	1.44T	1.29T	1.32T	1.36T
Stockholders Equity	7.92B	1.18T	1.13T	980.02B	894.18B	838.58B
Cash Flow
Free Cash Flow	-23.74B	62.26B	89.40B	37.08B	132.97B	71.81B
Operating Cash Flow	132.19B	242.84B	203.21B	135.56B	219.30B	164.84B
Investing Cash Flow	-115.64B	-329.38B	-226.09B	-10.40B	-56.41B	-115.98B
Financing Cash Flow	15.58B	58.13B	35.91B	-167.84B	-180.46B	-52.47B

Kirin Holdings Co Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 15.06
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KNBWY, the sentiment is Neutral. The current price of 15.06 is below the 20-day moving average (MA) of 15.13, below the 50-day MA of 15.09, and above the 200-day MA of 14.54, indicating a neutral trend. The MACD of -0.05 indicates Positive momentum. The RSI at 43.33 is Neutral, neither overbought nor oversold. The STOCH value of 15.32 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for KNBWY.

Kirin Holdings Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ABEV	80 Outperform	$41.67B	14.50	15.97%	8.22%	-0.68%	4.29%
BUD	75 Outperform	$135.76B	19.10	8.97%	1.83%	-2.06%	21.03%
CCU	70 Outperform	$2.65B	18.83	9.07%	2.53%	16.59%	1.72%
KNBWY	68 Neutral	$12.20B	21.88	6.93%	2.25%	5.64%	-22.32%
FMX	65 Neutral	$21.57B	46.33	5.48%	4.33%	1.44%	-38.87%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
TAP	53 Neutral	$9.99B	-4.74	-17.66%	4.08%	-4.01%	-339.22%